News articles about Intuitive Surgical (NASDAQ:ISRG) have trended somewhat positive recently, according to Accern Sentiment. Accern rates the sentiment of press coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Intuitive Surgical earned a news impact score of 0.21 on Accern’s scale. Accern also gave news stories about the medical equipment provider an impact score of 46.7483394851488 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.
These are some of the media headlines that may have impacted Accern Sentiment’s scoring:
- The case for Intuitive Surgical – Motley Fool (fool.com)
- Is Transenterix (NYSE: TRXC) Really A Threat To Intuitive Surgical … – Benzinga (benzinga.com)
- Robotic Rehabilitation and Assistive Technologies Market: Nascent Space Provides Ample Room for Growth to Players (itbusinessnet.com)
- Why TransEnterix Is Skyrocketing Today (finance.yahoo.com)
- Surgical robot maker buys $6M Durham building (finance.yahoo.com)
Several research analysts have recently commented on the stock. Vetr raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating and set a $113.37 price target for the company in a report on Thursday, August 17th. Wedbush reaffirmed a “buy” rating on shares of Intuitive Surgical in a report on Tuesday, October 10th. Cantor Fitzgerald assumed coverage on shares of Intuitive Surgical in a report on Thursday, June 29th. They issued a “neutral” rating and a $111.11 price target for the company. Morgan Stanley reaffirmed an “overweight” rating and issued a $118.89 price target (up from $105.56) on shares of Intuitive Surgical in a report on Tuesday, July 25th. Finally, Canaccord Genuity reaffirmed a “hold” rating and issued a $111.11 price target (up from $96.67) on shares of Intuitive Surgical in a report on Wednesday, July 26th. Five investment analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the company. Intuitive Surgical currently has an average rating of “Buy” and an average target price of $137.11.
Shares of Intuitive Surgical (ISRG) opened at 353.55 on Tuesday. Intuitive Surgical has a 52-week low of $203.57 and a 52-week high of $367.50. The firm’s 50 day moving average is $347.28 and its 200-day moving average is $310.58. The company has a market capitalization of $39.40 billion, a P/E ratio of 50.80 and a beta of 0.39.
Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, July 20th. The medical equipment provider reported $0.66 EPS for the quarter, topping analysts’ consensus estimates of $0.64 by $0.02. Intuitive Surgical had a net margin of 28.44% and a return on equity of 15.99%. The firm had revenue of $756.20 million for the quarter, compared to analyst estimates of $724.51 million. During the same quarter in the prior year, the firm earned $0.62 EPS. The company’s revenue was up 12.8% on a year-over-year basis. Equities research analysts anticipate that Intuitive Surgical will post $7.97 earnings per share for the current fiscal year.
In other Intuitive Surgical news, VP Jamie Samath sold 242 shares of the stock in a transaction dated Tuesday, July 25th. The shares were sold at an average price of $949.01, for a total transaction of $229,660.42. Following the sale, the vice president now owns 23 shares of the company’s stock, valued at approximately $21,827.23. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, SVP Mark J. Meltzer sold 500 shares of the stock in a transaction dated Tuesday, September 5th. The stock was sold at an average price of $1,025.00, for a total transaction of $512,500.00. Following the sale, the senior vice president now directly owns 2,796 shares in the company, valued at approximately $2,865,900. The disclosure for this sale can be found here. In the last three months, insiders have sold 23,172 shares of company stock worth $21,923,487. Insiders own 2.20% of the company’s stock.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.